Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 370.95
+2.90 (0.79%)
Nov 12, 2026, 3:29 PM IST
Biocon Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 174,145 | 169,270 | 152,617 | 147,557 | 111,742 | 81,840 |
Revenue Growth | 5.70% | 10.91% | 3.43% | 32.05% | 36.54% | 14.57% |
Gross Profit Gross Profit Growth | 107,170 | 102,664 | 92,441 | 91,735 | 69,617 | 50,111 |
Operating Income Operating Income Growth | 15,877 | 16,943 | 15,431 | 17,834 | 15,643 | 11,583 |
Net Income Net Income Growth | 4,521 | 3,856 | 10,133 | 10,225 | 4,627 | 6,484 |
Earnings Per Share EPS Growth | 2.94 | 2.82 | 8.46 | 8.54 | 3.87 | 5.42 |
EPS Growth | -24.70% | -66.67% | -0.94% | 120.67% | -28.60% | -12.44% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Biosimilars Biosimilars Growth | 109,165 | 104,312 | 90,174 | 88,242 | 55,838 | 34,643 |
Generics Generics Growth | 33,707 | 31,681 | 30,175 | 27,985 | 27,644 | 23,409 |
Services Services Growth | 35,223 | 37,387 | 36,424 | 34,886 | 31,929 | 26,042 |
Inter-Segment Inter-Segment Growth | -3,950 | -4,110 | -4,156 | -3,556 | - | - |
Total Total Growth | 174,145 | 169,270 | 152,617 | 147,557 | 111,742 | 81,840 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 26,867 | 38,831 | 45,651 | 25,740 | 37,263 | 29,649 |
Total Debt Total Debt Growth | 156,978 | 154,341 | 183,620 | 162,767 | 180,188 | 51,468 |
Net Cash (Debt) Net Cash Growth | -130,111 | -115,510 | -137,969 | -137,027 | -142,925 | -21,819 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -84.54 | -84.40 | -115.15 | -114.49 | -119.51 | -18.24 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 19,596 | 19,940 | 40,612 | 29,539 | 18,525 | 11,766 |
Capital Expenditures CapEx Growth | -16,249 | -17,979 | -21,366 | -16,805 | -15,960 | -16,978 |
Free Cash Flow Free Cash Flow Growth | 3,347 | 1,961 | 19,246 | 12,734 | 2,565 | -5,212 |
Free Cash Flow Growth | -82.88% | -89.81% | 51.14% | 396.45% | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 61.54% | 60.65% | 60.57% | 62.17% | 62.30% | 61.23% |
Operating Margin | 9.12% | 10.01% | 10.11% | 12.09% | 14.00% | 14.15% |
Pretax Margin | 2.08% | 2.65% | 12.36% | 10.34% | 8.03% | 12.01% |
Profit Margin | 2.60% | 2.28% | 6.64% | 6.93% | 4.14% | 7.92% |
FCF Margin | 1.92% | 1.16% | 12.61% | 8.63% | 2.30% | -6.37% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.500 | 0.500 | 0.500 | 1.500 | 0.500 |
Dividend Per Share Growth | 0% | 0% | 0% | -66.67% | 200.00% | - |
Dividend Yield | 0.13% | 0.14% | 0.15% | 0.19% | 0.73% | 0.15% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 126.18 | 151.47 | 40.36 | 30.85 | 53.21 | 61.56 |
Forward PE | 68.19 | 61.80 | 56.28 | 34.10 | 21.39 | 35.74 |
P/FCF Ratio | 180.46 | 297.84 | 21.25 | 24.77 | 95.98 | - |
PS Ratio | 3.47 | 3.45 | 2.68 | 2.14 | 2.20 | 4.88 |